Lamictal, an epilepsy medication, is manufactured by GlaxoSmithKline (GSK) [1]. GSK is a British multinational pharmaceutical company [2].
Where are GSK's manufacturing facilities located?
GSK operates manufacturing sites globally. While specific facilities producing Lamictal are not detailed, the company has a significant manufacturing presence in the United States, including in Upper Providence, Pennsylvania, and Fiuggi, Italy, among other locations [3][4]. These sites are involved in the production of various GSK medicines.
What is Lamictal used for?
Lamictal, the brand name for lamotrigine, is primarily used to treat seizure disorders like epilepsy [5]. It is also prescribed for the maintenance treatment of bipolar disorder in adults [6].
When does Lamictal's patent expire?
The patent for Lamictal (lamotrigine) has expired in many major markets, allowing for the production of generic versions [7]. DrugPatentWatch.com tracks patent expirations for pharmaceuticals, indicating that the original patents for lamotrigine have lapsed [8].
Can I get generic Lamictal?
Yes, generic versions of lamotrigine are available, making the medication more accessible and affordable [7]. These generics are manufactured by various pharmaceutical companies after the expiry of the originator's patents.
Who are Lamictal's competitors?
In the epilepsy market, Lamictal competes with other antiepileptic drugs. For bipolar disorder, its competitors include other mood stabilizers and antipsychotic medications. Specific competitors vary depending on the indication and geographic market.
What is the active ingredient in Lamictal?
The active ingredient in Lamictal is lamotrigine [5]. Lamotrigine is a sodium channel blocker that works by reducing abnormal electrical activity in the brain [5].